Analyst consensus rating
Inovio Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Inovio Pharmaceuticals's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked November 12, 2026.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.48
- Average price target
- $7.00
- High price target
- $8.00
- Low price target
- $5.00
- Low target gap
- +239%
- Target upside
- +374.6%
- High target gap
- +442.4%
- Target range width
- 203.4%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Inovio Pharmaceuticals?
Inovio Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $7.00.
How far are Inovio Pharmaceuticals's low and high targets from the recorded price?
The low target implies +239%, while the high target implies +442.4%.
How many analysts are included in Inovio Pharmaceuticals's consensus?
The verified consensus includes 3 analysts.
How is Inovio Pharmaceuticals's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $1.48, then one is subtracted to produce +374.6%. This does not guarantee a future return.
When was Inovio Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.